| Version |
2.5 |
| Creation Date |
2006-08-13 16:27:56 |
| Update Date |
2009-05-26 17:10:52 |
| Accession Number |
HMDB04259 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
Acetyl-N-formyl-5-methoxykynurenamine |
| Description |
Acetyl-N-formyl-5-methoxykynurenamine (AFMK) results from the oxidative cleavage of the pyrrole ring during melatonin oxidation by myeloperoxidase (MPO), a superoxide anion (O)-dependent reaction. AFMK is also expected to be formed from oxidation catalyzed by the unspecific enzyme indoleamine-2,3-dioxygenase (IDO), found in a variety of cell types including monocyte/macrophage lineages. MPO- and IDO-catalyzed melatonin oxidation has the requirement of O in common, a species formed in large amounts in inflammatory conditions. The non-enzymatic formation of AFMK can also be expected by its direct reaction with highly reactive oxygen species, such as hydroxyl radical and singlet oxygen. Thus, we assume that AFMK is a product formed in a route of melatonin metabolism, especially active in inflammation. As AFMK is biologically more active on leukocytes than melatonin, the metabolizing of melatonin to AFMK at inflammatory sites possibly plays a role in immunomodulation. AFMK is found in the CSF of patients with meningitis, and in some samples at a remarkably high concentration, with AFMK found in some patients exceeding the concentration of melatonin normally found in serum. (PMID: 16150112) |
| Synonyms |
- N-Acetyl-N-formyl-5-methoxykynurenamine
- AFMK
- Formyl-N-acetyl-5-methoxykynurenamine
- N-[3-(2-formamido-5-methoxy-phenyl)-3-oxo-propyl]acetamide
|
| Chemical IUPAC Name |
N-[3-(2-formamido-5-methoxy-phenyl)-3-oxo-propyl]acetamide |
| Chemical Formula |
C13H16N2O4 |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
| — |
| Class |
|
| Sub Class |
| — |
| Family |
|
| Species |
- ketone
- alkyl aryl ether
- secondary carboxylic acid amide
- aromatic compound
|
| Biofunction |
| — |
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
264.277 |
| Monoisotopic Molecular Weight |
264.110992 |
| Isomeric SMILES |
COC1=CC(C(=O)CCNC(C)=O)=C(NC=O)C=C1 |
| Canonical SMILES |
COC1=CC(C(=O)CCNC(C)=O)=C(NC=O)C=C1 |
| KEGG Compound ID |
C05642  |
| BioCyc ID |
Not Available |
| BiGG ID |
46183  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB04259  |
| Metagene Link |
HMDB04259  |
| METLIN ID |
Not Available |
| PubChem Compound |
171161  |
| PubChem Substance |
7953  |
| ChEBI ID |
Not Available |
| CAS Registry Number |
52450-38-1 |
| InChI Identifier |
InChI=1/C13H16N2O4/c1-9(17)14-6-5-13(18)11-7-10(19-2)3-4-12(11)15-8-16/h3-4,7-8H,5-6H2,1-2H3,(H,14,17)(H,15,16) |
| Synthesis Reference |
de Almeida Eduardo A; Martinez Glaucia R; Klitzke Clecio F; de Medeiros Marisa H G; Di Mascio Paolo Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5-methoxykynurenine. Journal of pineal research (2003), 35(2), 131-7. |
| Melting Point (Experimental) |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
0.169 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
0 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
-0.158
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
0.50 [Predicted by ALOGPS]; 0.6 [Predicted by PubChem via XLOGP]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
|
| MOL File |
Show |
| SDF File |
Show |
| PDB File |
Show |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Experimental 1H NMR Spectrum |
Not Available |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Not Available |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
Not Available |
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
|
| Biofluid Location |
- Blood
- Cerebrospinal Fluid
|
| Tissue Location |
Not Available |
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
0.000065 (0.000059-0.00189) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Harthe C, Claudy D, Dechaud H, Vivien-Roels B, Pevet P, Claustrat B: Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite. Life Sci. 2003 Aug 8;73(12):1587-97. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0 uM |
| Age |
Adult:>18 yrs old |
| Sex |
N/A |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6. [PubMed
]
|
|
| Concentrations (Abnormal) |
| Biofluid |
CSF |
| Value |
0.28 (0.06-0.50) uM |
| Age |
Adult:>18 yrs old |
| Sex |
N/A |
| Condition |
Meningitis |
| Comments |
Viral |
| References |
- Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6. [PubMed
]
|
|
| Associated Disorders |
| Condition |
References |
| Meningitis |
- Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6. [PubMed
]
|
|
| OMIM ID |
Not Available |
| Pathways |
|
| General References |
- Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6. [PubMed
]
|
| Metabolic Enzymes |
- Indoleamine 2,3-dioxygenase-like protein 1
|
|
Enzyme 1
[top]
|
| Enzyme 1 ID |
13115 |
| Enzyme 1 Name |
Indoleamine 2,3-dioxygenase-like protein 1 |
| Enzyme 1 Synonyms |
- Indoleamine-pyrrole 2,3-dioxygenase-like protein 1
|
| Enzyme 1 Gene Name |
INDOL1 |
| Enzyme 1 Protein Sequence |
>Indoleamine 2,3-dioxygenase-like protein 1
MEPHRPNVKTAVPLSLESYHISEEYGFLLPDSLKELPDHYRPWMEIANKLPQLIDAHQLQ
AHVDKMPLLSCQFLKGHREQRLAHLVLSFLTMGYVWQEGEAQPAEVLPRNLALPFVEVSR
NLGLPPILVHSDLVLTNWTKKDPDGNLETIISFPGGESLHGFILVTALVEKEAVPGIKAL
VQATNAILQPNQEALLQALQRLRLSIQDITKTLGQMHDYVDPDIFYAGIRIFLSGWKDNP
AMPAGLMYEGVSQEPLKYSGGSAAQSTVLHAFDEFLGIRHSKESGDFLYRMRDYMPPSHK
AFIEDIHSAPSLRDYILSSGQDHLLTAYNQCVQALAELRSYHITMVTKYLITAAAKAKHG
KPNHLPGPPQALKDRGTGGTAVMSFLKSVRDKTLESILHPRG
|
| Enzyme 1 Number of Residues |
402 |
| Enzyme 1 Molecular Weight |
44865 |
| Enzyme 1 Theoretical pI |
6.94 |
| Enzyme 1 GO Classification |
| Function |
- binding
- heme binding
- tetrapyrrole binding
|
| Process |
| — |
| Component |
| — |
|
| Enzyme 1 General Function |
Not Available |
| Enzyme 1 Specific Function |
Not Available |
| Enzyme 1 Pathways |
Not Available |
| Enzyme 1 Reactions |
Not Available |
| Enzyme 1 Pfam Domain Function |
|
| Enzyme 1 Signals |
|
| Enzyme 1 Transmembrane Regions |
|
| Enzyme 1 Essentiality |
Not Available |
| Enzyme 1 GenBank ID Protein |
34536196  |
| Enzyme 1 UniProtKB/Swiss-Prot ID |
Q6ZQW0  |
| Enzyme 1 UniProtKB/Swiss-Prot Entry Name |
I23OL_HUMAN  |
| Enzyme 1 PDB ID |
Not Available |
| Enzyme 1 Cellular Location |
Not Available |
| Enzyme 1 Gene Sequence |
Not Available |
| Enzyme 1 GenBank Gene ID |
AK128691  |
| Enzyme 1 GeneCard ID |
Q6ZQW0  |
| Enzyme 1 GenAtlas ID |
INDOL1  |
| Enzyme 1 HGNC ID |
HGNC:27269  |
| Enzyme 1 Chromosome Location |
Not Available |
| Enzyme 1 Locus |
Not Available |
| Enzyme 1 SNPs |
SNPJam Report  |
| Enzyme 1 General References |
Not Available |
| Enzyme 1 Metabolite References |
Not Available |